Article info
PDFOriginal article
Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer
- Correspondence to Professor Dr Peter Wild, Institute of Surgical Pathology, University Hospital Zurich, Schmelzbergstrasse 12, Zurich 8091, Switzerland; peter.wild{at}usz.ch
Citation
Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer
Publication history
- Received January 26, 2015
- Revised April 28, 2015
- Accepted May 25, 2015
- First published August 6, 2015.
Online issue publication
June 14, 2020
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
- Data supplement 1 - Online figures
Abstract in Deutsch
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
- Abstract in Deutsch - Online abstract
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/